vimarsana.com

Latest Breaking News On - Suresh durgam - Page 1 : vimarsana.com

Lumateperone Effective as Adjunctive Therapy for Major Depressive Disorder

The phase 3 study evaluated the efficacy and safety of lumateperone as an adjunctive treatment to antidepressants in 485 patients with MDD.

Suresh durgamDepression rating scaleExecutive vice presidentChief medical officer

Intra-Cellular Therapies, Inc (NASDAQ:ITCI) Q4 2023 Earnings Call Transcript

Intra-Cellular Therapies, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.44. Intra-Cellular Therapies, Inc.

United statesJessica fyeBrian abrahamsMark neumannAndrew tsaiLarry hinelineSuresh durgamJuan sanchezAmerican college of neuropsychopharmacologyCellular therapies incExchange commissionIntra cellular therapiesCall transcript februaryCellular therapiesIntra cellular therapie fourth quarterYear end financial results conference

Intra-Cellular Therapies Inc EVP, Chief Medical Officer Suresh Durgam Sells 6,167 Shares

Suresh Durgam, EVP, Chief Medical Officer of Intra-Cellular Therapies Inc (NASDAQ:ITCI), sold 6,167 shares of the company on February 2, 2024, according to a SEC Filing.

Cellular therapies incIntra cellular therapies incPossible value trapThink twiceIopharmaceutical companyChief medical officerSuresh durgam

Intra-Cellular Therapies Inc EVP Suresh Durgam Sells 62,282 Shares

Suresh Durgam, EVP and Chief Medical Officer of Intra-Cellular Therapies Inc (NASDAQ:ITCI), sold 62,282 shares of the company on January 2, 2024, according to a recent SEC Filing.

Cellular therapies incIntra cellular therapiesIntra cellular therapies incIopharmaceutical companySuresh durgamNeurological disordersChief medical officer

Intra-Cellular Therapies Inc s EVP, Chief Medical Officer Suresh Durgam Sells 21,262 Shares

In a notable insider transaction, EVP and Chief Medical Officer Suresh Durgam of Intra-Cellular Therapies Inc (NASDAQ:ITCI) sold 21,262 shares of the company's stock on December 13, 2023.

Cellular therapies incSuresh durgamIntra cellular therapies incSuresh durgamNtra cellular therapies incChief medical officerNsider transactionsInsider activityIopharmaceutical company

vimarsana © 2020. All Rights Reserved.